Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
RMI Pharmacokinetics is a specialized consulting firm and contract research organization (CRO) providing expert services in pharmacokinetics and drug metabolism. Founded in 2007 by Dr. Bob Ings, the company offers data analysis, strategic planning, and regulatory support for biotechnology and pharmaceutical companies globally. Their expertise spans various therapeutic areas, including oncology, CNS, and metabolic diseases, helping clients optimize drug candidates and navigate the complexities of early clinical development. The firm provides services such as pharmacokinetic modeling, preparation of regulatory documents like INDs and CTDs, and industry-focused training. Based in Carlsbad, California, RMI Pharmacokinetics serves a diverse clientele ranging from small biotechs to large pharmaceutical corporations and venture capitalists.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RMI-Pharmacokinetics.